Radical prostatectomy is potentially curative in patients with high-risk localized or locally advanced prostate cancer; however, relapse occurs within 5 years in up to 50% of patients. We conducted a ...

Please provide your email address to receive an email when new articles are posted on . Laser treatments, anti-VEGF injections and surgery can all be used to treat diabetic retinopathy. David Baxley, ...

Both robot-assisted simple prostatectomy (RASP) and laser enucleation of the prostate (LEP) are safe and effective surgical options for large-volume benign prostatic hyperplasia (BPH), according to a ...

Weihai Medison Medical Equipment Co., Ltd., a Chinese medical-device manufacturer founded in 2003 in Shandong Province, today launched VEMERIX, a new international brand positioning the company as a ...

The Expander-2 trial randomly assigned men with BPH symptoms at 23 sites in the US and Canada to receive a temporary nitinol urethral implant, Urocross Expander, or a sham procedure.

Calcified femoropopliteal arterial disease remains a major challenge in endovascular therapy. Vessel preparation technologies have emerged to improve ...

UVA Health Prince William Medical Center has begun offering Aquablation therapy, an advanced AI-powered treatment for benign ...

A 77-year-old man suffering from a severely enlarged prostate was treated using an advanced minimally invasive laser ...

the hospital, the patient had been suffering from prolonged difficulty in urination along with repeated episodes of urinary retention, which had considerably impacted his quality of life ...

Delhi: Doctors treat elderly with enlarged prostate using minimally invasive laser procedure | Latest News Delhi ...

Doctor explains minimally invasive laser procedure removes enlarged prostate, reduces bleeding, and prevents kidney failure ...

U.S. Market Projected to Hit USD 7.06 Billion by 2035 While Europe Market Expected to Reach USD 6.42 Billion as Aging Male Population Fuels Demand for Advanced BPH Therapies.Austin, United States, May ...